Sigmar Leyer

Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells

M. Tesar, M. Hallek, B. Rattel, 2002, Nature Medicine.

Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models.

Z. Nagy, F. Schwaiger, E. Rosloniec, 2006, Journal of autoimmunity.

294 1D09C3, a human, HLA-DR-specific monoclonal antibody efficiently induces programmed cell death in lymphoid tumors

B. Rattel, Z. Nagy, F. Schwaiger, 2004 .